Minerva Neurosciences (NERV) News Today → Exposed: 10 CENT Crypto to Explode April 20th? (From True Market Insiders) (Ad) Free NERV Stock Alerts $2.44 +0.01 (+0.41%) (As of 04/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlinePolice: 3 injured in Minerva Park single-vehicle crashmsn.com - April 20 at 10:08 AMOff-duty firefighters & neighbor rescue baby, residents from burning Minerva housemsn.com - April 20 at 10:08 AMMinerva Neurosciences (NASDAQ:NERV) Stock Crosses Below 200 Day Moving Average of $5.57americanbankingnews.com - April 20 at 3:34 AMPrairie voles display signs of human-like depression, show promise as animal modelmsn.com - April 4 at 8:40 PMNew track and field season gives Minerva sprinter Kyleigh Lippincott a fresh startmsn.com - March 31 at 2:50 AMPotts Point homelessness encampment moved on from Minerva-Metro Theatre sitemsn.com - March 14 at 9:56 PMMinerva Named "One to Watch" in Chartis Financial Crime and Compliance 50 Rankingstmcnet.com - March 14 at 9:56 PMRenovated Manti Temple, preserved Minerva Teichert murals ready for 3-week public open housemsn.com - March 13 at 10:46 PMMinerva Named Top AI & Data Product in the 2024 Product Awardstmcnet.com - March 13 at 12:45 PMHold Rating on Minerva Neurosciences Amid FDA Setbacks and Financial Constraintsmarkets.businessinsider.com - February 27 at 7:53 PMMinerva schizophrenia drug rejected by FDAfinance.yahoo.com - February 27 at 2:50 PMFDA Turns Away Minerva's Roluperidone Schizophrenia Drugmarketwatch.com - February 27 at 2:50 PMMinerva Neurosciences Shares Slide on Latest FDA Roluperidone Setbackmorningstar.com - February 27 at 2:50 PMRegulatory Setback For Minerva Neurosciences' Schizophrenia Treatment Candidate, FDA Asks For More Datamsn.com - February 27 at 2:50 PMMinerva falls as FDA rejects schizophrenia therapymsn.com - February 27 at 2:50 PMFDA rejects Burlington biotech’s schizophrenia drug, sends stock tumblingbizjournals.com - February 27 at 2:50 PMmarketbeat.com - February 27 at 9:35 AMUS FDA declines to approve Minerva Neurosciences' schizophrenia drugreuters.com - February 27 at 8:21 AMMinerva Neurosciences Receives Complete Response Letter from FDA for New Drug Application for Roluperidone for the Treatment of Negative Symptoms in Patients with Schizophreniafinance.yahoo.com - February 27 at 8:21 AMmarketbeat.com - February 27 at 7:59 AMREUTERS NEWS SCHEDULE AT 7:00 a.m. SGT /6:00 p.m. ETmsn.com - February 25 at 6:44 PM2NERV : Minerva Neurosciences: Q4 Earnings Insightsbenzinga.com - February 22 at 12:07 PMMinerva Neurosciences: Q4 Earnings Snapshotsfgate.com - February 22 at 12:07 PMMinerva Neurosciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Business Updatesfinance.yahoo.com - February 22 at 7:07 AMMinerva Neurosciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Business Updatesglobenewswire.com - February 22 at 7:00 AMSUNW, NSTG and NERV among mid-day moversseekingalpha.com - February 9 at 5:09 AMMarket Street Art Spot expands gallery and marks 13th anniversary in Minervamsn.com - February 7 at 10:32 AMMinerva Neurosciences (NASDAQ:NERV) Stock Passes Above 50-Day Moving Average of $6.77marketbeat.com - February 2 at 4:43 AMMinerva Neurosciences (NASDAQ:NERV) Stock Rating Lowered by StockNews.commarketbeat.com - February 2 at 1:26 AMGarth Evans set to become Minerva Local Schools' next athletic directormsn.com - January 31 at 1:29 AM'His fight is our fight': Malvern, Minerva basketball players learn life lessonmsn.com - January 17 at 9:49 AMMinerva Announces Channel Partner Program to Broaden the Reach of its AML Risk Assessment Solutionfinance.yahoo.com - January 16 at 7:31 AMEducation roundup: Minerva teacher is American Legion Educator of the Yearnews.yahoo.com - January 14 at 8:01 AMMinerva Neurosciences Inc NERVmorningstar.com - December 8 at 6:32 PMMinerva Neurosciences Reports 2023 Third Quarter Financial Results and Business Updatesmarkets.businessinsider.com - November 7 at 10:26 AMMinerva Neurosciences GAAP EPS of -$1.03 misses by $0.26msn.com - November 7 at 10:26 AMMinerva Neurosciences Reports 2023 Third Quarter Financial Results and Business Updatesfinance.yahoo.com - November 7 at 10:26 AMMeetings set on Minerva-Johnsburg school mergermsn.com - October 17 at 2:23 PMFirefighters battle railroad ties fire for 17+ hours just outside Minervanews.yahoo.com - October 13 at 9:25 PMHoming in on the importance of diversity in researchmsn.com - October 11 at 9:42 AMMarlington High School football scores on first 5 possessions, routs Minervamsn.com - October 7 at 9:53 AMCEO at Minerva Neurosciences Acquires Company Stock Options Worth 100,450 Sharesbenzinga.com - October 6 at 1:40 PMPresident at Minerva Neurosciences Acquires Company Stock Options Worth 87,050 Sharesbenzinga.com - October 6 at 1:40 PMPlymouth's oldest pub Minerva Inn is up for letmsn.com - October 4 at 7:54 AMMinerva Neurosciences: There's Probably Time For One More Rallymsn.com - August 23 at 4:48 AMMinerva Neurosciences Reports 2023 Second Quarter Financial Results and Business Updatesfinance.yahoo.com - August 1 at 7:34 PMMinerva Neurosciences, Inc: Minerva Neurosciences Announces $20 Million in Private Placement Priced at a Premium to Marketfinanznachrichten.de - June 28 at 1:26 PMMinerva Neurosciences shares are trading higher after the company announced a $20 million private placement priced at a premium to the market.benzinga.com - June 28 at 1:26 PMMinerva Neurosciences Shares Jump Premarket After Private Placementmarketwatch.com - June 28 at 1:26 PMWhy Minerva Neurosciences Stock Is Shooting Higher Todaymsn.com - June 28 at 1:26 PM Get Minerva Neurosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for NERV and its competitors with MarketBeat's FREE daily newsletter. Email Address The “Next Bitcoin”? 10 CENT Crypto Set to Explode (Ad)The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon… Click For My #1 FREE Crypto for 2024 NERV Media Mentions By Week NERV Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NERV News Sentiment▼0.240.32▲Average Medical News Sentiment NERV News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NERV Articles This Week▼31▲NERV Articles Average Week Get Minerva Neurosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for NERV and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Talphera News NeuroBo Pharmaceuticals News Galecto News Avalo Therapeutics News Aytu BioPharma News Pieris Pharmaceuticals News Orgenesis News RenovoRx News Flora Growth News BioVie News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NERV) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBiden out June 13; Kamala won’t replace him?Paradigm PressFed launches fourth dollar overhaulStansberry ResearchThe World's First "$20 Trillion Drug?"Behind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Minerva Neurosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
